Make your money go further for just 25p per day

Exciting biotech company, Motif Bio, plans to raise more new money within three months of listing

23/06/2015 · Motif Bio PLC (MTFB) 

Motif Bio plc (AIM: MTFB), a clinical stage biopharmaceutical company, which listed on AIM on 2nd April 2015 has today announced that it intends to raise £22m of new money through the placing of 44,000,000 new ordinary shares at a placing price of 50p.

Motif Bio is involved in the creation of novel antibiotics designed to be effective against antibiotic resistant bacteria. This is a very exciting and relevant area of scientific research as drug resistant bacteria are becoming an increasingly prevalent problem. 

In recent years antibiotics have become overused, and the more they are used the less effective they become. Common bacteria have evolved to overcome traditional antibiotics meaning many…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Motif Bio PLC

Who should you follow in the IPO lottery?

29/06/2015 · Smallcap Review
With 2014 seeing the highest number of new admissions to AIM since the glory days of…

Exciting biotech company, Motif Bio, plans to raise more new money within three months of listing

23/06/2015 · Company Insights
Motif Bio plc (AIM: MTFB), a clinical stage biopharmaceutical company, which listed on AIM on 2nd…

More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP